A defining characteristic of successful patient support programs is the level of cross-functional collaboration
There is a distinct difference between outstanding patient support programs and less effective programs. A defining characteristic of successful programs is the level of cross-functional collaboration. By following the six strategies in this white paper, pharmaceutical companies can improve collaboration, enhance the patient experience, better protect patient data, reduce risk, improve compliance—and improve the overall patient support program and patient journey.
For this whitepaper, Justine Hughes, Vice President, Archbow Consulting, aligned with four industry compliance and patient services experts on the strategies pharmaceutical companies can use to promote collaboration. Participants included:
- Laurie Hughes, Head of U.S. Patient Services, Biogen
- Rahul Khara, PharmD, Vice President, Legal and Chief Compliance Officer, Acceleron Pharma Inc.
- Terence Milton, JD, Director, Ethics & Compliance, Managed Healthcare Services and Consumer Experience, Eli Lilly and Company
- Michael Sanders, Market Access Strategy Lead, Orphan and Rare Disease, UCB